S02 E16: Pharma in South Africa, access, pricing and reimbursement

In this episode, GOLD speaks to Lenias Hwenda, Founder and CEO, Medicines for Africa, and Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Following on from GOLD’s recent ‘Pharma in South Africa’ feature, Lenias explains what the implementation of South Africa’s new healthcare system will mean for global pharma, as well as exploring genomics and market access. Alexander discusses his interest in pricing and access of pharmaceuticals, shares how value-based reimbursement is evolving and offers his thoughts on the new EU Health Technology Assessment procedure.    If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:   Pharma in South Africa https://www.emg-gold.com/post/pharma-in-south-africa Margo Warren on global access to medicine https://www.emg-gold.com/post/podcast-margo-warren-on-global-access-to-medicine Seeking solutions to low income, low access https://www.emg-gold.com/post/seeking-solutions-to-low-income-low-access Operation vaccines: access all areas https://www.emg-gold.com/post/operation-vaccines-access-all-areas

There are no comments yet.

Please log in to write the first comment.